Related Experiment Videos
Carcinogen-mediated oxidant formation and oxidative DNA damage
1Department of Environmental Medicine, Kaplan Comprehensive Cancer Center, New York University Medical Center, NY 10016-6451.
Pharmacology & Therapeutics
|January 1, 1992
Summary
Reactive oxygen species (ROS) and oxidative DNA damage are key factors in cancer development, particularly during tumor promotion. Inhibiting these processes with anticarcinogenic agents may prevent certain cancers.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Reactive oxygen species (ROS) are implicated in cellular damage.
- Oxidative DNA base damage is a known contributor to genetic instability.
- Tumor promotion involves complex genetic alterations.
Purpose of the Study:
- To review experimental evidence linking ROS and oxidative DNA damage to cancer.
- To emphasize the role of these factors in genetic changes during tumor promotion.
- To explore the potential of interrupting tumor promotion for cancer prevention.
Main Methods:
- Review of existing experimental data.
- Analysis of the mechanisms of anticarcinogenic agents.
- Correlation of ROS/DNA damage inhibition with tumor promotion inhibition.
Main Results:
- Experimental data supports the role of ROS and oxidative DNA damage in cancer.
- These damaging processes are significant in genetic changes during tumor promotion.
- Anticarcinogenic agents that inhibit ROS and DNA damage also inhibit inflammation and tumor promotion.
Conclusions:
- ROS and oxidative genetic damage are critical to the carcinogenic process.
- Interruption of tumor promotion cycles may offer a strategy for preventing certain cancers.
- Targeting ROS production and oxidative DNA damage is a promising therapeutic avenue.